Please use this identifier to cite or link to this item:
|Title:||Antimicrobial resistance: Not community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA)! A clinician's guide to community MRSA - its evolving antimicrobial resistance and implications for therapy.|
|Authors:||Chua, Kyra Y L;Laurent, Frederic;Coombs, Geoffrey W;Grayson, M Lindsay;Howden, Benjamin P|
|Affiliation:||Infectious Diseases, Austin Health, Heidelberg, Victoria, Australia|
|Citation:||Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America; 52(1): 99-114|
|Abstract:||There is significant diversity in methicillin-resistant Staphylococcus aureus (MRSA) clones arising in the community worldwide, with considerable geographical differences in typical antimicrobial resistance profiles. Many community clones of MRSA have a non-multidrug resistant antimicrobial profile, providing increased options for empirical and directed therapy of infections caused by these strains. However, the recent description of increasing non-β lactam resistance in community clones of MRSA, especially USA300, provides a timely warning for clinicians making decisions about therapy for patients potentially infected with these strains. Continued monitoring of global epidemiology and emerging drug resistance data is critical for the effective management of these infections.|
|Internal ID Number:||21148528|
Drug Resistance, Bacterial
Methicillin-Resistant Staphylococcus aureus.drug effects.isolation & purification
Microbial Sensitivity Tests
|Appears in Collections:||Journal articles|
Files in This Item:
There are no files associated with this item.
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.